Home › Bids
› Blueprint Neurotherapeutics Network (BPN): Small Molecule Dr
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
This grant opportunity, PAR-25-051, is for the Blueprint Neurotherapeutics Network (BPN) and supports small molecule drug discovery and development for disorders of the nervous system. It utilizes a UG3/UH3 phased award mechanism and includes an optional clinical trial component.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Small Molecule Drug Discovery Services
1
project
$2,000,000.00
$2,000,000.00
Professional Services
Drug Development Services
1
project
$2,000,000.00
$2,000,000.00
Professional Services
Preclinical Research Services
1
project
$1,000,000.00
$1,000,000.00
Professional Services
Clinical Trial Services (Optional)
1
trial
$5,000,000.00
$5,000,000.00
Medical
Estimated Bid Value
$10,000,000.00
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.